Min Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Min Yang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Min Li
College of Traditional Chinese Medicine, Jilin Agricultural Science and Technology University, Jilin, China
3 shared publications- Mohammad Darvishi
Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Department of Aerospace and Subaquatic Medicine, AJA University of Medical Sciences, Tehran, Iran
2 shared publications Xinglong Liu
College of Traditional Chinese Medicine, Jilin Agricultural Science and Technology University, Jilin, China
2 shared publicationsYing Zhang
College of Traditional Chinese Medicine, Jilin Agricultural Science and Technology University, Jilin, China
2 shared publicationsAnning Li
Jilin Aodong Yanbian Pharmaceutical Co, Ltd., Dunhua, China
1 shared publicationChuanbo Ding
College of Traditional Chinese Medicine, Jilin Agricultural Science and Technology University, Jilin, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
Preparation, Structure, Function, and Application of Dietary Polysaccharides from Polygonatum sibiricum in the Food Industry: A Review
Polygonatum sibiricum is one of the most widely used plants in the Liliaceae family, renowned for its dual medicinal and edible properties. Polygonatum sibiricum polysaccharides, as the main pharmacological active ingredient of Polygonatum sibiricum, have various excellent physiological activities, such as antioxidant, immune enhancement, and hypoglycemic activities. Through extraction, purification, and structural analysis, the influence and mechanism of the molecular weight and glycosidic bonds of Polygonatum sibiricum polysaccharides on the pharmacological effects, as well as their structure–activity relationship, can be explored in more detail. With the increasing demand for Polygonatum sibiricum polysaccharide products, Polygonatum sibiricum has been widely used in the fields of medicine, food, and biochemistry, and various green and harmless products containing Polygonatum sibiricum polysaccharides have been developed for different populations. This study summarizes the extraction, structure, and function of Polygonatum sibiricum polysaccharides, and it further explores their applications in the food industry, including in beverages, health foods, additives, and food packaging. Overall, Polygonatum sibiricum polysaccharides have been proven to be a promising natural product and have been introduced into the food system. It is worth mentioning that further efforts and time are needed in the future to expand the deep processing of and feasibility research on Polygonatum sibiricum polysaccharides while exploring their bioactive molecular mechanisms in depth, laying the foundation for their product development and clinical applications.
Top Cited PapersOpen AccessPreparation, Structure, Function, and Application of Dietary Polysaccharides from Polygonatum sibiricum in the Food Industry: A Review
Polygonatum sibiricum is one of the most widely used plants in the Liliaceae family, renowned for its dual medicinal and edible properties. Polygonatum sibiricum polysaccharides, as the main pharmacological active ingredient of Polygonatum sibiricum, have various excellent physiological activities, such as antioxidant, immune enhancement, and hypoglycemic activities. Through extraction, purification, and structural analysis, the influence and mechanism of the molecular weight and glycosidic bonds of Polygonatum sibiricum polysaccharides on the pharmacological effects, as well as their structure–activity relationship, can be explored in more detail. With the increasing demand for Polygonatum sibiricum polysaccharide products, Polygonatum sibiricum has been widely used in the fields of medicine, food, and biochemistry, and various green and harmless products containing Polygonatum sibiricum polysaccharides have been developed for different populations. This study summarizes the extraction, structure, and function of Polygonatum sibiricum polysaccharides, and it further explores their applications in the food industry, including in beverages, health foods, additives, and food packaging. Overall, Polygonatum sibiricum polysaccharides have been proven to be a promising natural product and have been introduced into the food system. It is worth mentioning that further efforts and time are needed in the future to expand the deep processing of and feasibility research on Polygonatum sibiricum polysaccharides while exploring their bioactive molecular mechanisms in depth, laying the foundation for their product development and clinical applications.
- Open Access
- 5 August 2024
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 12, 1428988
Antibacterial and antioxidant phlorizin-loaded nanofiber film effectively promotes the healing of burn wounds
Burns usually result in damage and loss of skin forming irregular wound wounds. The lack of skin tissue protection makes the wound site highly vulnerable to bacterial infections, hindering the healing process. However, commonly used wound dressings do not readily provide complete coverage of irregular wounds compared to regular wounds. Therefore, there is an urgent need to prepare a wound dressing with high antimicrobial efficacy for the administration of drugs to irregular wounds. In this study, a chitosan (CS)/polyvinylpyrrolidone (PVP) composite nanofiber membrane (CS/PVP/Phlorizin) loaded with root bark glycosides (Phlorizin) was developed using an electrostatic spinning technique. The incorporation of phlorizin, a natural antioxidant, into the fiber membranes notably boosted their antimicrobial and antioxidant capabilities, along with demonstrating excellent hydrophilic characteristics. In vitro cellular experiments showed that CS/PVP/Phlorizin increased Hacat cell viability with the presence of better cytocompatibility. In scald wound healing experiments, Phlorizin-loaded nanofibrous membranes significantly promoted re-epithelialization and angiogenesis at the wound site, and reduced the inflammatory response at the wound site. Therefore, the above results indicate that this nanofiber membrane is expected to be an ideal dressing for burn wounds.
- 5 August 2024
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 12, 1428988
Open AccessAntibacterial and antioxidant phlorizin-loaded nanofiber film effectively promotes the healing of burn wounds
Burns usually result in damage and loss of skin forming irregular wound wounds. The lack of skin tissue protection makes the wound site highly vulnerable to bacterial infections, hindering the healing process. However, commonly used wound dressings do not readily provide complete coverage of irregular wounds compared to regular wounds. Therefore, there is an urgent need to prepare a wound dressing with high antimicrobial efficacy for the administration of drugs to irregular wounds. In this study, a chitosan (CS)/polyvinylpyrrolidone (PVP) composite nanofiber membrane (CS/PVP/Phlorizin) loaded with root bark glycosides (Phlorizin) was developed using an electrostatic spinning technique. The incorporation of phlorizin, a natural antioxidant, into the fiber membranes notably boosted their antimicrobial and antioxidant capabilities, along with demonstrating excellent hydrophilic characteristics. In vitro cellular experiments showed that CS/PVP/Phlorizin increased Hacat cell viability with the presence of better cytocompatibility. In scald wound healing experiments, Phlorizin-loaded nanofibrous membranes significantly promoted re-epithelialization and angiogenesis at the wound site, and reduced the inflammatory response at the wound site. Therefore, the above results indicate that this nanofiber membrane is expected to be an ideal dressing for burn wounds.
- Open Access
- 25 March 2023
- Published by Springer Nature in Cancer Cell International
- Vol. 23 (1) , 1
Correction: The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies
- 25 March 2023
- Published by Springer Nature in Cancer Cell International
- Vol. 23 (1) , 1
Open AccessCorrection: The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies
- Open Access
- 10 February 2023
- Published by Springer Nature in Cancer Cell International
- Vol. 23 (1) , 1-22
The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies
After skin malignancy, breast cancer is the most widely recognized cancer detected in women in the United States. Breast cancer (BCa) can happen in all kinds of people, but it's much more common in women. One in four cases of cancer and one in six deaths due to cancer are related to breast cancer. Angiogenesis is an essential factor in the growth of tumors and metastases in various malignancies. An expanded level of angiogenesis is related to diminished endurance in BCa patients. This function assumes a fundamental part inside the human body, from the beginning phases of life to dangerous malignancy. Various factors, referred to as angiogenic factors, work to make a new capillary. Expanding proof demonstrates that angiogenesis is managed by microRNAs (miRNAs), which are small non-coding RNA with 19–25 nucleotides. MiRNA is a post-transcriptional regulator of gene expression that controls many critical biological processes. Endothelial miRNAs, referred to as angiomiRs, are probably concerned with tumor improvement and angiogenesis via regulation of pro-and anti-angiogenic factors. In this article, we reviewed therapeutic functions of miRNAs in BCa angiogenesis, several novel delivery carriers for miRNA-based therapeutics, as well as CRISPR/Cas9 as a targeted therapy in breast cancer.
- 10 February 2023
- Published by Springer Nature in Cancer Cell International
- Vol. 23 (1) , 1-22
Open AccessThe various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies
After skin malignancy, breast cancer is the most widely recognized cancer detected in women in the United States. Breast cancer (BCa) can happen in all kinds of people, but it's much more common in women. One in four cases of cancer and one in six deaths due to cancer are related to breast cancer. Angiogenesis is an essential factor in the growth of tumors and metastases in various malignancies. An expanded level of angiogenesis is related to diminished endurance in BCa patients. This function assumes a fundamental part inside the human body, from the beginning phases of life to dangerous malignancy. Various factors, referred to as angiogenic factors, work to make a new capillary. Expanding proof demonstrates that angiogenesis is managed by microRNAs (miRNAs), which are small non-coding RNA with 19–25 nucleotides. MiRNA is a post-transcriptional regulator of gene expression that controls many critical biological processes. Endothelial miRNAs, referred to as angiomiRs, are probably concerned with tumor improvement and angiogenesis via regulation of pro-and anti-angiogenic factors. In this article, we reviewed therapeutic functions of miRNAs in BCa angiogenesis, several novel delivery carriers for miRNA-based therapeutics, as well as CRISPR/Cas9 as a targeted therapy in breast cancer.